
David-James Sebag
David-James Sebag is a Partner in Gide's Corporate/Mergers & Acquisitions team and divides his time between the New York and Paris offices. His practice focuses primarily on mergers and acquisitions and private equity, with a particular emphasis on cross-border transactions. David-James represents a large number of international groups and private-equity funds for their investments in France, and advises French companies on their fund-raising and acquisitions in France and the United States. He regularly advises investors and entrepreneurs on M&A, venture and growth equity transactions, particularly in the tech, AI , healthcare sectors or sensitive businesses (for foreign investment control). David-James has recently advised Talend (NASDAQ), on its acquisition by Thoma Bravo for USD 2.4 billion; TPG Capital and Planview, a US-based strategic portfolio management (SPM) platform, for the acquisition of Sciforma Corporation; Hitachi Vantara, the French subsidiary of Hitachi, Ltd. on the sale of oXya SAS, an SAP infrastructure solution provider, to Montefiore Investment; Tenable Holdings Inc. (NASDAQ) in the acquisition of Alsid, a French cybersecurity company; Hana Group and its management for the LBO of TA Associates, the subsequent build-up acquisition of Genji in the US and the secondary buy-out of Permira; Temasek for its investments in French leading companies Alan and ManoMano; Vitalliance, its founder and shareholders for the LBO with ISAI and secondary LBO with Parquest; MWM, Spendesk, Odaseva and other growth companies for their equity financings in France and the US. David-James is a lawyer at the Paris and New York bars. · Gide Loyrette Nouel
About
Partner in Gide Loyrette Nouel's Corporate/Mergers & Acquisitions team, splitting his time between Paris and New York and focusing on mergers & acquisitions and private equity with an emphasis on cross-border transactions. He advises international groups, private-equity funds and French companies on investments, fund-raisings and acquisitions in France and the United States, and regularly handles venture and growth equity matters in the technology, AI and healthcare sectors as well as foreign investment control issues.
Practice areas
Office
Expertise
Admissions
- Paris Bar
- New York Bar